Guide
Lifespan and healthspan: the difference, and why it matters
6 min read · last reviewed 22 August 2026
Lifespan is how long you live. Healthspan is how long you live in good health — free of major disease and disability. The two are related but not the same, and almost everything interesting in ageing research lives in the gap between them.
Why the distinction changes the research
Measuring lifespan in a human trial requires following people until they die — decades, for most participants. Measuring healthspan is more tractable: physical function, disease onset, and disability can be measured within a trial's lifetime. This is why serious human ageing trials measure things like strength, walking ability, infection rates or cardiometabolic risk, and why no supplement trial has ever measured human lifespan.
It is also why healthspan-adjacent measures dominate this site's evidence tables. When we grade a claim about physical function, that is a real health outcome. When a study measures only a blood marker, we label it a surrogate — a stand-in whose improvement may or may not translate into anything you would notice.
Compression of morbidity: the actual goal
The most useful framing in ageing research is the idea of compressing morbidity — squeezing the years of illness at the end of life into a shorter window, so that healthspan approaches lifespan. An intervention that added years of disability would technically extend lifespan and be a poor bargain; one that added no years but converted five frail years into five functional ones would show up nowhere in mortality statistics and be transformative.
This is why population statistics distinguish life expectancy from healthy life expectancy, and why the gap between them — often a decade or more — is arguably the most important number in the field.
How to apply this when reading claims
When you see a longevity claim, ask which target it is actually about. Strength training has evidence relevant to healthspan — function, independence, and an association with lower mortality. NAD+ boosters have evidence about a biomarker, which is a claim about neither. And nothing sold today has human lifespan evidence. Sorting claims into those three buckets — healthspan outcome, surrogate marker, untested — takes seconds and defuses most marketing.